Copy
Result of the 4th open call for data partners
Tweet Tweet
Share Share
Forward Forward

EHDEN grows its federated network by adding 41 new data partners, reaching a total of 98 data partners in 22 countries.

The EHDEN Consortium is pleased to announce that a total of 41 data partners have been selected in our latest open call for data partners. Having received a total of 55 eligible applications, these 41 applications were selected by the EHDEN Data Source Prioritisation Committee. Combined, the 41 selected data partners represent over 78 million patient records, originating from various care settings.

This open call had a focus on countries minimally represented in the current EHDEN network, and with this current call, we now have data partners in 7 new countries: Greece, Bulgaria, Israel, Norway, Sweden, Switzerland and Luxembourg. Secondly, the oncology focus was a huge success with 12 new data partners having a focus on oncology while we also welcome several new data partners with a focus on Diabetes Mellitus. EHDEN looks forward to all the new Data Partners joining with the 60 Data Partners across the 16 countries from our prior three calls.

We will now be initiating the process of signing a sub-grant agreement with these 41 data partners while in parallel a work plan will be worked out and linkage to one of the EHDEN-certified SMEs will be initiated. We anticipate that the first mappings will start after summer.

If you are interested in applying to a future call, then follow us via our website, social media channels or subscribe to our newsletter to stay up to date on all upcoming open calls. More information about the Data Partner Calls can be found here.

Below is the list of selected Data Partners, grouped per country:

·         Belgium

o   Ziekenhuis Oost-Limburg

o   AZ Delta

·         Bulgaria

o   National Scientific Programme "E-Health in Bulgaria"

·         Croatia

o   FREYR Ltd. & University Hospital Centre Zagreb

·         Finland

o   Pirkanmaa Hospital District

o   Hospital District of Helsinki and Uusimaa

·         France

o   APHP-EDS

o   Centre Hospitalier Universitaire de Montpellier

o   Assistance Publique - Hopitaux de Marseille

·         Germany

o   Hanover Medical School, Germany

o   University Medicine Dresden

o   CancerDataNet GmbH

·         Greece

o   Innovative Medical Research SA

o   GENERAL HOSPITAL OF KAVALA

·         Israel

o   The Directorate of Government Medical Centers at the Israeli Ministry Of Health

·         Italy

o   Fondazione Istituto Nazionale dei Tumori

o   Azienda Ospedaliera Universitaria Integrata Verona

o   IRCCS Policlinico San Donato

o   Fondazione IRCCS Policlinico San Matteo

o   Modena Oncology Center - Azienda Ospedaliera Modena

o   Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo

o   ATS Bergamo

·         Luxembourg

o   Registre National du Cancer du Luxembourg

·         The Netherlands

o   IKNL

o   EBMT: The European Society for Blood and Marrow Transplantation

·         Norway

o   University of Oslo, Department of Pharmacy, Pharmacoepidemiology and Drug Safety Research Group

·         Portugal

o   Hospital da Luz Learning Health

o   APDP

·         Serbia

o   Univerzitetski klinički centar Niš

o   Kliničko-bolnički centar Zvezdara

·         Spain

o   Servicio Madrileno de Salud

o   Rioja Salud

·         Sweden

o   MEB KI

·         Switzerland

o   HUG and SCQM

o   Geneva Cancer Registry

·         UK

o   University of Edinburgh

o   Connected Bradford

o   DECOVID

o   GOSH

o   Optimum Patient Care Limited

o   Queen Mary University of London

Website
Twitter
LinkedIn
YouTube
GitHub
Email
Copyright © EHDEN, All rights reserved.

Disclaimer
This newsletter reflects the views of the EHDEN consortium and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.

Acknowledgement
The European Health Data & Evidence Network has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
 
Want to change how you receive these emails?
You can
update your preferences or unsubscribe from this list.
 






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Ehden · X · X · X, B 08591 · Spain

Email Marketing Powered by Mailchimp